Nectar Lifesciences Limited (NSE:NECLIFE)

Nectar Lifesciences Revenue

Nectar Lifesciences had revenue of 145.00K INR in the quarter ending June 30, 2026, a decrease of -99.99%. This brings the company's revenue in the last twelve months to 145.00K, down -100.00% year-over-year.

• Revenue (ttm): 145.00K
• Revenue Growth: -100.00%
• P/S Ratio: 15,406.90
• Revenue / Employee: 1.31K
• Employees: 111
• Market Cap: 2.23B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	-	-	-
Mar 31, 2025	-	-	-
Mar 31, 2024	16.85B	1.61B	10.56%
Mar 31, 2023	15.24B	-1.45B	-8.70%
Mar 31, 2022	16.69B	1.26B	8.13%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error